The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation

Recruiting now · Not applicable

Conditions studied: COPD (Chronic Obstructive Pulmonary Disease), Symptom Management, Self-care Agency

In brief

According to the 2024 GOLD guidelines, Chronic Obstructive Pulmonary Disease (COPD) is defined as heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. COPD is one of the leading causes of mortality and morbidity in Turkey and worldwide. Since COPD is an incurable and lifelong disease, it is important for patients to have high levels of self-management. The main questions it aims to answer are: 1. Does self-management education and telephone follow-up intervention effect self-care agency and symptom management in people with COPD exacerbation? 2. Does self-management education effect self-care agency and symptom management in people with COPD exacerbation? This study will evaluate the effect of self-management education and telephone follow-up on self-care agency and symptom management. Patients hospitalized with COPD exacerbation will be trained in the hospital and will be followed up by phone call after discharge. During the study, 3 groups were planned; Group 1 will be educated and followed up by telephone Group 2 will only receive education and no telephone follow-up. Group 3 will not receive education and telephone follow-up, only standard care. It is planned to collect the data from the patients at the beginning of the study, at 1, 3 and 6 months. Main outcomes: * Level of self-care agency * Level of symptom management The results obtained will be interpreted by comparing between 3 groups.

Key facts

Study ID

NCT06707649

Run by

Kirsehir Ahi Evran Universitesi

People needed

150

Starts

2024-09-01

Expected to finish

2025-10-01

Last updated by the study team

2024-11-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with COPD for the last 1 year
• Diagnosis of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage III or IV COPD documented by pulmonary function testing
• Patients hospitalized for acute exacerbation of COPD;
• Hospitalized for at least 3 days
• Having a personal mobile phone and the ability to use it,
• Being enough conscious and oriented to answer the questions,
• Voluntary patients

You may not qualify if…

• Under 18 years old
• Withdrawal from the study at any phase
• Inability to be contacted by phone/mobile phone,
• Patient death

Where it is running

• Kirsehir Training and Research Hospital — Kırşehir, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.